This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Saggiorato, E. Articles by Orlandi, F. Search for Related Content PubMed PubMed Citation Articles by Saggiorato, E. Articles by Orlandi, F.

Galectin-3 as a Presurgical Immunocytodiagnostic Marker of Minimally Invasive Follicular Thyroid Carcinoma

Department of Clinical and Biological Sciences (E.S., A.M., G.P., P.C., A.A., F.O.), University of Turin, and Department of Pathology (S.C., P.D.G.), San Luigi Hospital, 10043 Orbassano, Turin, Italy

Address all correspondence and requests for reprints to: Fabio Orlandi, M.D., Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Regione Gonzole 10, 10043 Orbassano (TO), Italy. E-mail: fabio.orlandi{at}unito.it

Abstract

Thyroid nodules are a common occurrence in the general population, but only a small number of them are eventually diagnosed as cancers. Fine-needle aspiration biopsy (FNAB) is the most accurate and cost-effective method for the presurgical management of thyroid nodules, but it misses the differential diagnosis between thyroid follicular adenomas and follicular carcinomas. Among them, minimally invasive follicular carcinoma (MIC), also defined as encapsulated tumor, only differs from follicular adenoma for the exhibition of minimal, but entire thickness, infiltration of the capsule and/or vascular invasion. This feature cannot be assessed in FNAB and can occasionally be hard to recognize in surgical specimens. As reported in several studies, galectin-3 is a reliable marker of thyroid malignancy, but no data are available on MICs. We analyzed the immunohistochemical expression of galectin-3 in 17 MICs and 52 follicular adenomas in both preoperative paraffin-embedded cytological human thyroid sediments (cell blocks) obtained by FNAB and in the corresponding surgical specimens. Among the MICs, all surgical samples showed galectin-3 immunoreactivity in the cytoplasm, whereas 16 of 17 corresponding FNAB cell blocks were positive. No evidence of cytoplasmic galectin-3 expression was observed in 48 of 52 adenomas in both cell blocks and histological tissues. These findings indicate that galectin-3 is a reliable presurgical molecular marker of MIC, improving the accuracy of conventional FNAB. It also proves to be useful in the histopathological assessment of resected tumors having suspected malignant features.

This article has been cited by other articles:

				E. Saggiorato, T. Angusti, R. Rosas, M. Martinese, M. Finessi, F. Arecco, E. Trevisiol, N. Bergero, B. Puligheddu, M. Volante, et al. 99mTc-MIBI Imaging in the Presurgical Characterization of Thyroid Follicular Neoplasms: Relationship to Multidrug Resistance Protein Expression J. Nucl. Med., November 1, 2009; 50(11): 1785 - 1793. [Abstract] [Full Text] [PDF]

				M. R. Sapio, A. Guerra, D. Posca, P. P. Limone, M. Deandrea, M. Motta, G. Troncone, A. Caleo, P. Vallefuoco, G. Rossi, et al. Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma Endocr. Relat. Cancer, December 1, 2007; 14(4): 1089 - 1097. [Abstract] [Full Text] [PDF]

				M. Eszlinger, K. Krohn, A. Kukulska, B. Jarzab, and R. Paschke Perspectives and Limitations of Microarray-Based Gene Expression Profiling of Thyroid Tumors Endocr. Rev., May 1, 2007; 28(3): 322 - 338. [Abstract] [Full Text] [PDF]

				M Niedziela Pathogenesis, diagnosis and management of thyroid nodules in children. Endocr. Relat. Cancer, June 1, 2006; 13(2): 427 - 453. [Abstract] [Full Text] [PDF]

				E Saggiorato, R De Pompa, M Volante, S Cappia, F Arecco, A P Dei Tos, F Orlandi, and M Papotti Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application Endocr. Relat. Cancer, June 1, 2005; 12(2): 305 - 317. [Abstract] [Full Text] [PDF]

				F. Weber, L. Shen, M. A. Aldred, C. D. Morrison, A. Frilling, M. Saji, F. Schuppert, C. E. Broelsch, M. D. Ringel, and C. Eng Genetic Classification of Benign and Malignant Thyroid Follicular Neoplasia Based on a Three-Gene Combination J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2512 - 2521. [Abstract] [Full Text] [PDF]

				D. J. Finley, N. Arora, B. Zhu, L. Gallagher, and T. J. Fahey III Molecular Profiling Distinguishes Papillary Carcinoma from Benign Thyroid Nodules J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3214 - 3223. [Abstract] [Full Text] [PDF]

				C. Torres-Cabala, A. Panizo-Santos, H. C. Krutzsch, H. Barazi, M. Namba, M. Sakaguchi, D. D. Roberts, and M. J. Merino Differential Expression of S100C in Thyroid Lesions International Journal of Surgical Pathology, April 1, 2004; 12(2): 107 - 115. [Abstract] [PDF]

				A.-C. Gerard, C. Daumerie, C. Mestdagh, S. Gohy, C. de Burbure, S. Costagliola, F. Miot, M.-C. Nollevaux, J.-F. Denef, J. Rahier, et al. Correlation between the Loss of Thyroglobulin Iodination and the Expression of Thyroid-Specific Proteins Involved in Iodine Metabolism in Thyroid Carcinomas J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4977 - 4983. [Abstract] [Full Text] [PDF]

				K. Boelaert, C. J. McCabe, L. A. Tannahill, N. J. L. Gittoes, R. L. Holder, J. C. Watkinson, A. R. Bradwell, M. C. Sheppard, and J. A. Franklyn Pituitary Tumor Transforming Gene and Fibroblast Growth Factor-2 Expression: Potential Prognostic Indicators in Differentiated Thyroid Cancer J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2341 - 2347. [Abstract] [Full Text] [PDF]

				C. B. Barden, K. W. Shister, B. Zhu, G. Guiter, D. Y. Greenblatt, M. A. Zeiger, and T. J. Fahey III Classification of Follicular Thyroid Tumors by Molecular Signature: Results of Gene Profiling Clin. Cancer Res., May 1, 2003; 9(5): 1792 - 1800. [Abstract] [Full Text] [PDF]

				S. B. Savin, D. S. Cvejic, and M. M. Jankovic Expression of Galectin-1 and Galectin-3 in Human Fetal Thyroid Gland J. Histochem. Cytochem., April 1, 2003; 51(4): 479 - 483. [Abstract] [Full Text] [PDF]

				L. Cheung, M. Messina, A. Gill, A. Clarkson, D. Learoyd, L. Delbridge, J. Wentworth, J. Philips, R. Clifton-Bligh, and B. G. Robinson Detection of the PAX8-PPAR{gamma} Fusion Oncogene in Both Follicular Thyroid Carcinomas and Adenomas J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 354 - 357. [Abstract] [Full Text] [PDF]

				L. Martins, S. E. Matsuo, K. N. Ebina, M. A. V. Kulcsar, C. U. M. Friguglietti, and E. T. Kimura Galectin-3 Messenger Ribonucleic Acid and Protein Are Expressed in Benign Thyroid Tumors J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4806 - 4810. [Abstract] [Full Text] [PDF]